Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 5
2005 6
2006 4
2007 2
2008 7
2009 6
2010 6
2011 12
2012 7
2013 6
2014 3
2015 10
2016 8
2017 8
2018 3
2019 6
2020 16
2021 18
2022 14
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola, Jahnsen J, Louis E, Lukáš M, Reinisch W, Roblin X, Smith PJ, Kwon T, Kim J, Yoon S, Kim DH, Atreya R. Peyrin-Biroulet L, et al. Among authors: smith pj. BMC Gastroenterol. 2024 Mar 27;24(1):121. doi: 10.1186/s12876-024-03163-5. BMC Gastroenterol. 2024. PMID: 38539103 Free PMC article.
Top 10 research priorities for digital technology for adolescents and young persons with inflammatory bowel disease: Results of a James Lind Alliance Priority Setting Partnership.
Narula P, Gasparetto M, Wong C, Branchflower J, Sebastian S, McLaughlin J, Rao A, Wakeman R, Ainley R, Smith PJ, Kammermeier J, Younge L, Randall S, Bukhari S, Manson J, Ellis P, Arebi N; James Lind Alliance Priority Setting Partnership for Digital Technology for Adolescents and YP with Inflammatory Bowel Disease. Narula P, et al. Among authors: smith pj. J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):670-676. doi: 10.1002/jpn3.12105. Epub 2024 Jan 4. J Pediatr Gastroenterol Nutr. 2024. PMID: 38504402 Review.
Nurse-led approach to standardising the management of iron-deficiency anaemia, achieving the 2-week cancer pathway targets and reducing hospital admissions: practicalities and learnings from a success story.
Reid P, Patterson K, McCulloch E, Walsh L, Murshid A, Kinsella W, Moore A, Skouras T, Smith PJ. Reid P, et al. Among authors: smith pj. Frontline Gastroenterol. 2023 Nov 20;15(2):162-169. doi: 10.1136/flgastro-2023-102438. eCollection 2024 Mar. Frontline Gastroenterol. 2023. PMID: 38486670 Free PMC article.
Young persons and healthcare professionals experience of virtual gastroenterology consultations: a multicentre survey conducted during the COVID-19 pandemic.
Hubbard R, Brooks A, Arebi N, El-Khouly S, Kiparissi F, Mozdiak E, Muhammed R, Smith PJ, Zarate-Lopez N, Garrick V, Greenan-Barrett J, Baker S, Bradbury K, DelNero N, Narula P. Hubbard R, et al. Among authors: smith pj. Frontline Gastroenterol. 2023 Jun 6;14(6):491-496. doi: 10.1136/flgastro-2022-102354. eCollection 2023. Frontline Gastroenterol. 2023. PMID: 37854783 Free PMC article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
143 results